Conclusions: Our findings highlight survivin as a critical mediator of cell proliferation in HPV− HNSCC and suggest that targeting the CDK4/6-USP1-survivin axis may offer a promising therapeutic strategy. This evidence concerns the gene CDK4 and head and neck squamous cell carcinoma.